Andor Health Says CMS Recognized ThinkAndor Platform
Andor Health and Psynergy Health said the Centers for Medicare & Medicaid Services (CMS) recognized ThinkAndor for reaching General Availability in the CMS Health Technology Ecosystem initiative, the companies announced in a press release. The company said the recognition applies to existing ThinkAndor capabilities, not a new product launch.
Andor said it committed to the patient facing Conversational AI Assistant and Kill the Clipboard categories under the CMS Interoperability Framework. General Availability means those capabilities are operating in production, according to the announcement.
ThinkAndor lets patients scan a QR code to access care, retrieve health information, use conversational AI, complete digital intake, and receive guidance reviewed by clinicians. Andor said the platform is used by more than 10 million patients across 40 health systems.
Psynergy Health, an Andor Ventures company, is described as a CMS approved ACCESS Model clinic. Andor said ThinkAndor and Psynergy Health combine AI infrastructure, licensed clinicians, and clinical operations for health systems participating in the CMS ACCESS Model.
We hope you enjoyed this article.
Consider subscribing to one of our newsletters like Enterprise AI Brief, Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from: Enterprise
More from: Life Sciences
Subscribe to Enterprise AI Brief
Weekly report on AI business applications, enterprise software releases, automation tools, and industry implementations.
Market report
2025 Generative AI in Professional Services Report
This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.
Read more